Search Results - "RITUXIMAB"

Case Report: sustained five-year remission in eosinophilic granulomatosis with polyangiitis with intestinal perforation after surgery and rituximab-based therapy without glucocorticoid escalation.

Authors: Yamamura Y Matsumoto Y Ohashi K et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jul 01; Vol. 17, pp. 1849453. Date of Electronic Publication: 2026 Jul 01 (Print Publication: 2026).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Long-term outcomes of patients with moderate-severe pediatric systemic lupus erythematosus treated with combination rituximab and cyclophosphamide therapy: A single center cohort experience and review of literature.

Authors: Achar A Houser P Cherian J et al.

Source: Lupus [Lupus] 2026 Jul; Vol. 35 (8), pp. 842-850. Date of Electronic Publication: 2026 Apr 08.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0962 (Electronic) Linking ISSN: 09612033 NLM ISO Abbreviation: Lupus Subsets: MEDLINE

The application of rituximab during the conditioning regimen prevents Epstein - Barr virus infection following rATG-based haploidentical hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxis.

Authors: Hao J Zhang T Ren J et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jun 19; Vol. 17, pp. 1795239. Date of Electronic Publication: 2026 Jun 19 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Obinutuzumab versus rituximab-based chemotherapy in high-tumor burden indolent B-cell lymphoma: a real-world comparative study.

Authors: Wan X Liu D Wang H et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jun 18; Vol. 17, pp. 1857350. Date of Electronic Publication: 2026 Jun 18 (Print Publication: 2026).

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Efficacy of low dose of rituximab to treat systemic lupus erythematosus.

Authors: Chen Y Xu L Wang Y et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jun 16; Vol. 17, pp. 1806879. Date of Electronic Publication: 2026 Jun 16 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

[Efficacy and safety of rituximab in children with refractory nephrotic syndrome].

Authors: Bai W Xu K Su BG et al.

Source: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics [Zhongguo Dang Dai Er Ke Za Zhi] 2026 Jun 15; Vol. 28 (6), pp. 729-735.

Publication Type: English Abstract; Journal Article

Journal Info: Publisher: Zhongguo dang dai er ke za zhi she Country of Publication: China NLM ID: 100909956 Publication Model: Print Cited Medium: Print ISSN: 1008-8830 (Print) Linking ISSN: 10088830 NLM ISO Abbreviation: Zhongguo Dang Dai Er Ke Za Zhi Subsets: MEDLINE

A predictive model for low-dose rituximab response in anti-acetylcholine receptor antibody-positive myasthenia gravis: establishment and validation.

Authors: Hou C Zhang Y Cao X et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jun 03; Vol. 17, pp. 1781372. Date of Electronic Publication: 2026 Jun 03 (Print Publication: 2026).

Publication Type: Journal Article; Validation Study

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Synergistic Interaction Between MALAT1/miR-30b-5p/BAFF Axis and Inflammatory Cytokines Underlies Rituximab-Refractory NMOSD.

Authors: Deng M Zeng K Chen W et al.

Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2026 Jun; Vol. 32 (6), pp. e70973.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print Cited Medium: Internet ISSN: 1755-5949 (Electronic) Linking ISSN: 17555930 NLM ISO Abbreviation: CNS Neurosci Ther Subsets: MEDLINE

Case Report: Successful treatment of recurrent COVID-19 with intravenous immunoglobulin in a patient with rituximab-induced B-cell depletion and restoration of Fc-mediated effector functions.

Authors: Jo HB Kang JS Choi S et al.

Source: Frontiers in immunology [Front Immunol] 2026 May 25; Vol. 17, pp. 1797070. Date of Electronic Publication: 2026 May 25 (Print Publication: 2026).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Comparative efficacy of ripertamab, rituximab, and efgartigimod in chronic inflammatory demyelinating polyneuropathy: an exploratory real-world multicenter cohort study.

Authors: Wu Y Zhou Y Yin W et al.

Source: Frontiers in immunology [Front Immunol] 2026 May 19; Vol. 17, pp. 1825584. Date of Electronic Publication: 2026 May 19 (Print Publication: 2026).

Publication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort.

Authors: Stögbauer J Bewarder M Groß L et al.

Source: Frontiers in immunology [Front Immunol] 2026 May 12; Vol. 17, pp. 1738865. Date of Electronic Publication: 2026 May 12 (Print Publication: 2026).

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy.

Authors: Freeman WJ Rife EC Cron RQ

Source: Frontiers in immunology [Front Immunol] 2026 May 04; Vol. 17, pp. 1798455. Date of Electronic Publication: 2026 May 04 (Print Publication: 2026).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study.

Authors: Savolainen M Soilu-Hänninen M Nurmi H et al.

Source: European journal of neurology [Eur J Neurol] 2026 May; Vol. 33 (5), pp. e70625.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE

Real-World Experience With Single Ultra-Low Dose Rituximab for Remission Induction in Pemphigus.

Authors: Jeng YC Liu WT Hsu CK et al.

Source: The Journal of dermatology [J Dermatol] 2026 Jul; Vol. 53 (7), pp. 1057-1061. Date of Electronic Publication: 2026 May 22.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1346-8138 (Electronic) Linking ISSN: 03852407 NLM ISO Abbreviation: J Dermatol Subsets: MEDLINE

Efficacy and safety of obinutuzumab in patients with primary membranous nephropathy: a focus on refractory and rituximab-resistant patients.

Authors: Gao Q Yao G Sun Y et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jun 26; Vol. 17, pp. 1825745. Date of Electronic Publication: 2026 Jun 26 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Treatment strategies for rituximab-resistant primary membranous nephropathy: from resistance mechanisms to emerging therapies.

Authors: Gao J Pei Y Wei L et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jun 11; Vol. 17, pp. 1844062. Date of Electronic Publication: 2026 Jun 11 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Idiopathic multiple castleman disease case combined with severe neuropathy, Sjogren's syndrome and membrane nephropathy treated by rituximab: a case report and literature review.

Authors: Wang S Chen T Liu S et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jun 05; Vol. 17, pp. 1804654. Date of Electronic Publication: 2026 Jun 05 (Print Publication: 2026).

Publication Type: Journal Article; Case Reports; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion.

Authors: Alping P Öberg Sysojev A Piehl F et al.

Source: European journal of neurology [Eur J Neurol] 2026 Jun; Vol. 33 (6), pp. e70656.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE

Successful use of intravitreal rituximab as salvage therapy for relapsed vitreoretinal lymphoma.

Authors: Cristescu IE Pagnacco C Pershad S et al.

Source: Indian journal of ophthalmology [Indian J Ophthalmol] 2026 Jun 01; Vol. 74 (6), pp. 870-875. Date of Electronic Publication: 2026 May 27.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Medknow Publications Country of Publication: India NLM ID: 0405376 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1998-3689 (Electronic) Linking ISSN: 03014738 NLM ISO Abbreviation: Indian J Ophthalmol Subsets: MEDLINE

Rituximab is associated with accelerated dialysis independence in anti-glomerular basement membrane disease: a retrospective cohort analysis of renal survival.

Authors: Wang Y Zhai Z Wang L et al.

Source: Frontiers in immunology [Front Immunol] 2026 May 11; Vol. 17, pp. 1835889. Date of Electronic Publication: 2026 May 11 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE